Skip to main content

News

Filter by:
  • SCK CEN - SWD-event (2026)

    'Not everything that comes from dismantling is necessarily radioactive waste'

    SCK CEN attracts international attention with cutting-edge techniques for a circular approach to dismantling

    Today, more than 70 industry, policy and research representatives looked over the shoulder of SCK CEN’s dismantling experts. There, experts demonstrated the measurement and other techniques that enable the reuse and recycling of materials during the dismantling of nuclear facilities.

  • SCK CEN - Dag tegen Kanker (2026)

    SCK CEN also pins on a yellow ribbon for 'Day against Cancer'

    Last year, an impressive 370,000 people wore the yellow ribbon to show their support for cancer patients and their families. Today, on the 27th edition of Day against Cancer in Flanders, we will be pinning our ribbons again, together with our colleagues. Matthias D'Huyvetter explains why he will be doing the same. “It's a way of saying: I see you, I hear you, I feel you.”

  • Inspectie pre-licensing.JPEG

    From VENUS to LEANDREA: building on years of research

    The European EU-SMR-LFR programme aims to shorten the traditionally long timelines associated with nuclear projects by involving nuclear regulators from the very beginning of the reactor development process. To that end, an international pre-licensing programme has been underway since 2025, enabling the consortium to engage early with regulators and align on expectations and safety requirements.

    As part of this programme, experts from FANC, CNCAN and the IAEA recently visited several SCK CEN facilities. During the visit, they were also introduced to another key asset for LEANDREA: the VENUS zero-power reactor, a unique research infrastructure that SCK CEN has been using since 2011 to conduct experiments on fast reactor systems.

    This head start in terms of both expertise and infrastructure, combined with the early engagement of nuclear regulators through the pre-licensing process, is expected to help accelerate the development of LEANDREA.